FSC Wealth Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,300	Closed	-$499K	–	224
2022 Q3	$499K	Hold	3,300	–	–	4.81%	4
2022 Q2	$481K	Hold	3,300	–	–	4.26%	4
2022 Q1	$391K	Buy	3,300 +300	+10%	+$35.5K	0.37%	18
2021 Q4	$413K	Buy	+3,000	New	+$413K	0.28%	26